HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dimitrios T Trafalis Selected Research

Cytochrome P-450 CYP2E1 Inducers

3/2010CYP2E1 and risk of chemically mediated cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dimitrios T Trafalis Research Topics

Disease

33Neoplasms (Cancer)
01/2024 - 03/2010
8Melanoma (Melanoma, Malignant)
02/2024 - 04/2019
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2021 - 07/2018
4Breast Neoplasms (Breast Cancer)
11/2020 - 01/2017
3Hypothyroidism
01/2023 - 05/2022
3Lung Neoplasms (Lung Cancer)
12/2021 - 06/2020
3Hematologic Neoplasms (Hematological Malignancy)
10/2021 - 06/2008
3Carcinoma (Carcinomatosis)
08/2021 - 12/2019
3Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 11/2017
2Thyroid Neoplasms (Thyroid Cancer)
06/2022 - 01/2020
2Chronic Disease (Chronic Diseases)
11/2021 - 04/2019
2Hypophysitis
01/2021 - 06/2020
1Diabetes Mellitus
04/2023
1COVID-19
11/2021
1Microsatellite Instability
06/2021
1Necrosis
02/2021
1Infections
02/2021
1Femoral Fractures (Femoral Fracture)
02/2021
1Hypocalcemia
02/2021
1Second Primary Neoplasms (Neoplasms, Second)
02/2021
1Osteonecrosis (Kienbock's Disease)
02/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Osteoporosis
01/2021
1Hypotension (Low Blood Pressure)
12/2020
1Hyponatremia
12/2020
1Addison Disease (Addison's Disease)
12/2020
1Hyperkalemia
12/2020
1Adenocarcinoma
12/2020
1Fatigue
12/2020
1Hyperpigmentation
12/2020
1Carcinogenesis
11/2020
1Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)
06/2020

Drug/Important Bio-Agent (IBA)

9Immune Checkpoint InhibitorsIBA
04/2023 - 01/2019
5IsothiocyanatesIBA
02/2024 - 04/2019
5LigandsIBA
01/2023 - 01/2019
4Lysine (L-Lysine)FDA Link
02/2024 - 03/2020
4Thyroid HormonesIBA
01/2023 - 12/2021
4ThiadiazolesIBA
01/2023 - 01/2020
4Alkylating AgentsIBA
08/2021 - 03/2011
4SteroidsIBA
08/2021 - 03/2011
4DenosumabFDA Link
02/2021 - 01/2020
4CTLA-4 AntigenIBA
01/2021 - 01/2020
4NivolumabIBA
12/2020 - 07/2018
4Bevacizumab (Avastin)FDA Link
01/2020 - 09/2012
3Histones (Histone)IBA
02/2024 - 02/2021
3Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2020
3PhytochemicalsIBA
04/2023 - 04/2019
3LactamsIBA
08/2021 - 03/2011
3Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2011
2Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2023 - 06/2022
2SilverIBA
01/2023 - 11/2021
2MethyltransferasesIBA
12/2021 - 08/2015
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2021 - 11/2017
2DNA (Deoxyribonucleic Acid)IBA
08/2021 - 11/2017
2Monoclonal AntibodiesIBA
01/2021 - 12/2019
2Programmed Cell Death 1 ReceptorIBA
12/2020 - 06/2020
2Cytostatic AgentsIBA
05/2020 - 03/2011
2Irinotecan (Camptosar)FDA LinkGeneric
01/2020 - 04/2016
2EstersIBA
12/2018 - 03/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2018 - 09/2012
2liposomal doxorubicin (Doxil)FDA Link
07/2018 - 07/2012
1tazemetostatIBA
02/2024
1Polycomb Repressive Complex 2IBA
02/2024
1resazurinIBA
04/2023
1hydroxide ionIBA
03/2023
1PhosphinesIBA
01/2023
1tesmilifene (DPPE)IBA
01/2023
1xantphosIBA
01/2023
1Anti-Bacterial Agents (Antibiotics)IBA
01/2023
1ThioamidesIBA
01/2023
1bis(diphenylphosphine)ethane (bis(diphenylphosphino)ethane)IBA
01/2023
1Bacterial DNAIBA
06/2022
1Bexarotene (LGD1069)FDA Link
05/2022
1Interleukin-2 (IL2)IBA
05/2022
1Interferon-alpha (Interferon Alfa)IBA
05/2022
1Tyrosine Kinase InhibitorsIBA
05/2022
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
12/2021
1CaspasesIBA
11/2021
1lissamine rhodamine B (sulforhodamine B)IBA
11/2021
1EnzymesIBA
08/2021
1Glutathione (Reduced Glutathione)IBA
02/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2021
1Indicators and Reagents (Reagents)IBA
02/2021
1TransferasesIBA
02/2021
1sulforaphaneIBA
02/2021
1Histone Deacetylases (Histone Deacetylase)IBA
02/2021
1iberin (IMSP)IBA
02/2021
1OsteoprotegerinIBA
01/2021
1Adrenocorticotropic Hormone (ACTH)FDA Link
01/2021
1GlucocorticoidsIBA
01/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021
18-nitroguanineIBA
10/2020
18-Hydroxy-2'-DeoxyguanosineIBA
10/2020

Therapy/Procedure

15Therapeutics
03/2023 - 09/2012
6Drug Therapy (Chemotherapy)
05/2022 - 03/2011
3Immunotherapy
06/2021 - 01/2019
2Radiotherapy
05/2022 - 09/2012
2Continuity of Patient Care
05/2022 - 11/2021
2Palliative Care (Palliative Therapy)
01/2017 - 07/2012
1Adjuvant Radiotherapy
10/2020